Clinical Trials Directory

Trials / Completed

CompletedNCT02815046

Mixed Urinary Incontinence Symptoms Before and After Treatment With Botox and Bulkamid

Prospective, Non-randomized, Single-center Observational Study of Outcome Measures of Patients Suffering From Mixed Urinary Incontinence Before and After Surgical Procedure With Botulinum Toxin and Polyacrylamide Hydrogel (PAHG)

Status
Completed
Phase
Study type
Observational
Enrollment
58 (actual)
Sponsor
Prof. Dr. Volker Viereck · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study compares mixed urinary incontinence symptoms before and after a combined treatment with Botox and Bulkamid. Eligible for the study are adult females with a mixed urinary incontinence, having both urgency urinary symptoms and stress urinary symptoms.

Conditions

Interventions

TypeNameDescription
DRUGBotulinum toxin type AIntravesical injections of Botulinum toxin A (Botox) into the bladder wall.
DEVICEPolyacrylamide hydrogelMidurethral injections of the bulking Agent Bulkamid into the submucosal tissues of the urethra.

Timeline

Start date
2016-08-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2016-06-28
Last updated
2020-03-12

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02815046. Inclusion in this directory is not an endorsement.